IBIO
iBio Inc
Halal Rating :
Last Price
$2.86
Last updated:
Market Cap
-
7D Change
15.32%
1 Year Change
167.29%
Company Overview
Industries
Exchange
Next Earnings Date
iBio Inc is a biotechnology company focused on developing next-generation biopharmaceuticals and manufacturing proteins using its FastPharming® and Glycaneering™ Technologies. The company aims to discover and develop novel antibodies and other biological products for the treatment of fibrotic and infectious diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $175000.0 | $4.64m | - | $60000.0 | 0.00% | 1.29% |
Company Impact
Help us evaluate iBio Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.